EGFR and esophageal squamous cell carcinoma: Zhang et al. [9] confirmed that in ESCC cell lines with EGFR high expression when the EGFR signal was activated, the expression of PD-L1 was significantly increased, and when the EGFR tyrosine kinase inhibitor was applied, the expression was significantly inhibited.